- About Us
- Orthobiologics
- Dermal
- Surgical
-
Return to Life Naturally.
Learn More -
Feel Stronger. Go Further.
Get Moving -
Manage Wounds.
Explore Dermal -
Protection Against Adhesions.
Safety Matters
Our Response to COVID-19
Anika Therapeutics is closely monitoring the evolving COVID-19 (coronavirus) situation and the guidance from global, national and local health authorities. We have taken several steps to safeguard the health of our employees worldwide, support the needs of our partners, and ensure patients have the treatments they need. We are also actively working with industry partners to donate supplies to meet the urgent needs of healthcare providers.
In accordance with guidance issued by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and local health authorities, we have directed our employees to work remotely from home whenever possible. We have cancelled or postponed all face-to-face meetings and events and halted business travel until further notice to help reduce the spread of the virus. In addition, we have implemented additional protective measures at all of our production facilities and provided guidance to all Anika employees regarding proper health and hygiene practices in accordance with recommendations from global, national, and local health authorities.
We are closely monitoring our manufacturing and supply chain resources and we are taking measures to ensure product availability globally. At this time, we do not anticipate disruption to the supply of our products for patients due to COVID-19. We have also taken measures to minimize any disruption to ongoing clinical trials and are working with trial sites and other partners to ensure our trials continue to be conducted in a safe manner.
Our hearts go out to everyone impacted by COVID-19 during this uncertain time. Patients who have questions or concerns regarding their treatments with our products should contact their health care provider. For questions about our products, please contact customerservice@anikatherapeutics.com. Information and guidance on COVID-19 is available from the WHO and CDC.
-
Spotlight
Tactoset™ is a new injectable bone substitute which contains Anika’s proprietary hyaluronic acid formulation.
US Customer Service
US Customer Service: 888-721-1600
customerservice@anikatherapeutics.com